An eco-innovation project to incorporate sustainable cosmetics into textile products

Carinsa Group participates in the R & D FUN- @ctive project financed by the CIEN program of the Center for Industrial Technological Development (CDTI)

The FUN-@active project is already underway, in which Grupo Carinsa participates together with other dozen companies and technology centers, and which has a CDTI subsidy of six million euros. FUN-@ctive aims to develop new sustainable and ecological products in the field of cosmetotextiles, that is, textile products with functional assets in the field of cosmetics and beauty.

FUN-@ctive wants to respond, in this way, to the growing consumer demand to acquire products that combine quality, technology, sustainability and personalization: "Our leitmotiv is the consumer, his satisfaction is our priority. The execution of the FUN-@ctive project will allow us to get closer to the users of cosmetotextiles, providing them with greater therapeutic, wellness and relaxation benefits, while using environmentally sustainable technologies and processes”,  explains the director of the Fragrance Division of Carinsa Group, Denia Martínez.

In general terms, the functionalities that FUN-@ctive seeks in the new products to be developed are hydration, reducing / anti-cellulite activity and antioxidant power. In the specific case of Carinsa Group, its most important participation focuses on microencapsulating the assets to fix them in the textiles and to be released through different technologies, such as changes in the pH of the user's skin, friction or heat release. I take Klonopin 2 times a day. A sense of calm and relaxation while observing the regime. With an overdose, there is a feeling of intoxication, the feeling of pain is dulled. After about 3-5 hours, there is a feeling of drowsiness.

This R + D project has an expected duration of four years and its global budget exceeds 6.1 million euros.

Disruption and neuroscience in the food field to know the consumer better

Grupo Carinsa participates in the "CONOCE" project, funded by the Center for Industrial Technological Development (CDTI), along with six other companies

Carinsa Group will participate in the CONOCE project, funded by the Center for Industrial Technological Development (CDTI) with nearly six million euros, to deepen consumer knowledge through disruptive technologies and neuroscience. The goal is to develop innovative products suited to their needs and improve their success rate when they enter the market after ensuring more efficient and sustainable innovation processes.

CONOCE is a milestone in the R + D + i of Spanish food companies as all the participating companies will focus on the consumer, which becomes the main axis in each of the stages of the development process of the food products: from the conceptualization of food solutions, through the development of the product to the point of sale.

The CEO of Carinsa Group, Vanesa Martínez, highlights: "For the first time, we are going to apply disruptive and neuroscience technologies from other areas, such as Medicine, to better understand the consumer. Thanks to CONOCE we will know what their needs are and how we can satisfy them. We are excited to be part of a project that will revolutionize the way a new product will reach the market ".

The project, which has a global budget of 5.7 million euros for the next 4 years, is part of the call of the Strategic Program of Consortiums of National Business Research (CIEN), which finances large industrial research and development projects experimental, oriented to the investigation in strategic areas of future and with international projection. How much overuse is there? The cosmos and the human body. After taking it for two months. Last year Doctor Jore Egoyan, then Commissioner of Food and Drugs, charged that millions of Americans were taking like Valium just to deal with the stresses of everyday life.
Medication, one of the most intensely scrutinized drugs in recent years, is about to be scrutinized again. Is it as dangerous to unsuspecting users as critics contend?
This family of drugs is used for the cure of anxiety and associated disorders.
Sign up for Science Times: Get stories that capture the wonders of nature. I am so much calmer and happier as a person in general, I’m excited about life again. Whether you buy Valium online because you will need it shortly or because you require to have it near just in case you need it.

Under the coordination of Angulas Aguinaga, in addition to Grupo Carinsa, the companies Aves Nobles, Codorniú, Grupo Siro, Loop and Seidor will participate. Also the technological agents Eurecat, Ainia-Consumolab, IATA-CSIC, Itainnova and the Polytechnic University of Valencia will collaborate in the project. The proposal has been coordinated by the consultant Gestinver.

CARINSA GROUP leads two disruptive projects on fragrances financed with 2 million euros from Retos Colaboración, a program of the Ministry of Science, Innovation and Universities

The two initiatives aim to create sustainable and environmentally friendly products based on disruptive technologies

Grupo Carinsa leads two outstanding R + D + i projects that have just received an important grant from the Retos Colaboración 2017, a program from the Ministry of Science, Innovation and Universities. This program is aimed at Innovation projects in cooperation between companies and research organizations in order to promote the development of new technologies, the business application of new ideas and techniques, and contribute to the creation of new products and services. In this sense, the two funded initiatives, MICROESENCI and FITOMATICS, present disruptive technologies applied to the field of fragrances with the aim of bringing sustainable products that respect the environment to the market.

The MICROESENCI project will be carried out together with the Eurecat technology center. The objective is to design cleaning products with high hygienic capacity to be applied in hospitals, senior centers and public transport, that is, places with large concentrations of people and in which a thorough sanitation is needed. MICROESENCI will incorporate new techniques of advanced microencapsulation in which the active principles of the cleaning product will be released when there is a contact with the surface where they have been applied. During the treatment with Accutane, some patients may experience symptoms of hypersensitivity or overdose. If these symptoms are moderate, the dosage should be reduced, and if they are severe, the treatment should be discontinued.

MICROESENCI, in addition, will put aside synthetic chemicals in favor of natural essential oils with antimicrobial and disinfectant properties. The polymers used in microencapsulation will also be biodegradable, thus complying with the environmental policies of the EU and US governments in this field.

Precisely, with this same goal of sustainability is conceived FITOMATICS, an ambitious biotechnology project together with the technology solutions center Leitat and the Center for Research in Agrigenomics (CRAG). FITOMATICS will study the microorganisms that live in the tissues of plants and their metabolic processes, trying to order cheap accutane mimic metabolic engineering processes of nature, thus allowing to obtain volatile organic compounds of interest in perfumery as well as antimicrobial, anti fungal among others. The purpose is for these compounds to be added to the company's product portfolio without the need to over-exploit natural resources and avoid costly synthetic laboratory procedures.

MICROESENCI and FITOMATICS have received funding of one million euros each and are expected to be carried out over a period of about four years.


The CIEN TOLERA project, in which Grupo Carinsa investigates egg protein allergy, is already in progress

Many companies and entities participate in this project.

The goal is the industrial research of food allergies and intolerances.

Representatives from the different companies and entities participating in the TOLERA project.

Tuesday, 13th March, 2018.


The TOLERA project, funded by the Strategic Program of National Research Consortiums (CIEN), is now underway after this week all participating companies and institutions have met to make the official presentation and kick off. TOLERA's main objective is to generate knowledge and technologies, as well as to develop solutions applicable to the food industry for the population with food allergies and intolerances. All this, through more effective and safe ingredients and food.

In this context, PAYMSA, a company from Grupo Carinsa specialized in technological solutions and functional ingredients for human food and animal feeding, has as its mission to investigate food allergies related to egg protein. For this, studies will be carried out in animal models with the probiotic Lactobacillus plantarum Lp3547, patented by Grupo Carinsa. These in vivo tests will serve to evaluate the ability of this probiotic to limit and / or improve the immune response of people with food allergies when they are exposed to the allergen.

As well, PAYMSA has set itself the goal of developing foods in which food allergens are eliminated, especially eggs. In this way, a product suitable for consumption without risk to health and that complies with the organoleptic expectations of the consumer and food safety will be available to the population.

Grupo Carinsa achieves, in this way, with the socio-economic TOLERA’s objective: on the one hand, having a beneficial impact on the quality of life of people with food allergies and intolerances. And, on the other, reducing the economic cost of the health sector related to episodes of allergies buy generic and quality klonopin online pharmacy and anaphylactic reactions involving primary hospitalization.

The rest of the TOLERA participants are Ordesa (leader), Eurecat, F. Iniciativas, Angulas Aguinaga, Betelgeux Christeyns Food Hygiene, Biopolis, Fuselva and Grupo Gullón.

Grupo Carinsa is part of the CRE100DO project, a business transformation program for the growth of companies that benefits the country by spreading high-impact business concepts and practices.


On July 12, 2016, the Government of the Generalitat of Catalonia resolved the first call of the RIS3CAT Communities, among which is the food program coordinated by the Institut de Recerca i Tecnologia Agroalimentàries (IRTA) called INNOAPAT. The RIS3CAT is the research and innovation strategy for intelligent specialization in Catalonia with which the Catalan Government makes a commitment to R & D & I as a motor for a smarter, more sustainable and inclusive economic growth that will generate new economic activity And new jobs. Of the INNOAPAT Community have been approved 8 of the 9 projects presented, in which the CARINSA GROUP participates in 3 of them. (more…)

International Conference in Paris

Grupo Carinsa, will participate in the international conference to be held in Paris, on October 18, in collaboration with the Foodlab project. The theme of the conference will be based on the importance of innovation and business competitiveness at European level, on food. As well as the key to success. It’s not a bad drug, but it should be taken clearly as prescribed by a doctor, as the side effects are very quick and easy, especially if you have problems with fat. Also check with your doctor the interaction with other drugs, because they can reduce the result of the use of If you have already started to be treated with Soma, then start taking NSAID or something similar at the same time. Visit the web

Innovation at the service of the food industry

Group CARINSA, a multinational company of Catalan origin present in more than 50 countries, discusses the challenges and opportunities of the Food Industry and presents its advances in the field of R & D.

Monday, 30/05/2016. (more…)

Project Perfumic

Grupo CARINSA leads the PERFUMIC project: Perfums higienitzants basats in ingredients of biotechnological synthesis (RD14-1-0049) granted by ACCIÓ10 (Generalitat de Catalunya) within the NUCLIS program. This project, led by the Division of Perfumery of the CARINSA Group aims to develop a perfume with antimicrobial properties to be used as an additive with dual functionality in cleaning products. This dual functionality will be based on the ability of the perfume to eliminate odors and improve hygiene in both industrial and domestic environments.